Bristol Myers Squibb Drug Patent Portfolio

Bristol Myers Squibb's Family Patents


Family Patents



Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Bristol Myers Squibb News

Could the Recent Label Expansion of BMY's Opdivo Enhance Its Immuno-Oncology Portfolio? - TradingView

25 Mar, 2026

Johnson & Johnson Receives USFDA Approval for Oral Psoriasis Medication Icotyde - Medical Dialogues

19 Mar, 2026

FDA grants approval for Johnson & Johnson's oral medication for psoriasis - ET Pharma

18 Mar, 2026

FTC Increases Antitrust Scrutiny on Pharmaceutical Industry as Major Drug Patents Near Expiration

18 Mar, 2026

See More